Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2012

View Archived Issues

Negative findings reported from LEAP study of CO-101

Novel biguanide inhibits cell proliferation and cyst growth of human ADPKD cells

Vertex presents in vitro results for a novel CFTR corrector

Nerviano Medical Sciences patents novel protein kinase inhibitors

GlaxoSmithKline discloses new TRPV1 antagonists

French team synthesizes novel ALK tyrosine kinase receptor inhibitors

New S1P1 receptor agonists presented by French and Indian researchers

Bayer Intellectual Property divulges novel GCS activators

Laboratoire Biodim prepares new anti-HIV agents

Promising phase I results presented for myrcludex B

Immunomic Therapeutics begins phase I study of JRC-LAMP-vax vaccine

Phase III pancreatic cancer study of Abraxane meets primary endpoint

Astellas partners with Japanese universities for antiprotozoan drugs

FDA approves Prezista 800-mg tablets for the treatment of HIV

Novartis files supplemental NDA for Neoral in Japan

China's State Food and Drug Administration approves first-in-human trial of APX-003

RedHill Biopharma concludes pre-NDA meeting with FDA for RHB-103

PATH's Drug Development program to advance antidiarrheal candidate

Phase I/IIa study of RPh-201 in chronic vegetative patients begins in Israel

FDA advisory committee schedules review of Zohydro

Advanced Cell Technology reports interim clinical data on hESC-derived RPE cells

Interim results presented for a peptide-based cancer vaccine

U.S. screening begins for new phase Ib study of PRTX-100

First patient receives NiCord stem cell transplant in pilot study

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...